PHR

Phreesia Inc
NYSEHEALTHCAREHEALTH INFORMATION SERVICES

Key Statistics

Market Cap
$671.28M
P/E Ratio
67.88
EPS
$0.16
Beta
0.87
52W High
$32.76
52W Low
$7.77
50-Day MA
$9.89
200-Day MA
$13.84
Dividend Yield
Profit Margin
1.85%
Forward P/E
14.16
PEG Ratio

About Phreesia Inc

Phreesia, Inc. provides integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company is headquartered in Raleigh, North Carolina.

Official WebsiteUSAFY End: January

Fundamentals

Revenue (TTM)$495.59M
Gross Profit (TTM)$336.20M
EBITDA$32.83M
Operating Margin5.15%
Return on Equity2.86%
Return on Assets1.48%
Revenue/Share (TTM)$8.23
Book Value$5.81
Price-to-Book1.83
Price-to-Sales (TTM)1.35
EV/Revenue1.362
EV/EBITDA15.95
Quarterly Earnings Growth (YoY)0.00%
Quarterly Revenue Growth (YoY)12.90%
Shares Outstanding$61.81M
Float$49.92M
% Insiders4.38%
% Institutions97.94%

Historical Volatility

HV 10-Day
47.25%
HV 20-Day
41.33%
HV 30-Day
51.88%
HV 60-Day
52.07%
HV Rank
56.3%

Volatility is currently contracting

Analyst Ratings

Consensus ($13.94 target)
3
Strong Buy
8
Buy
8
Hold

Latest News

PHREESIA, INC. (NYSE: PHR) SHAREHOLDER INVESTIGATION ALERT: Bernstein Liebhard Investigates Potential Breaches of Fiduciary Duty

NEW YORK, July 29, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP , a nationally recognized investor rights law firm, announces that it is investigating potential breaches of fiduciary duty by certain directors and officers of Phreesia, Inc. (“Phreesia” or the “Company”) (NYSE: PHR). The investigation seeks to determine whether the Company's leadership fulfilled its obligations to shareholders and whether legal remedies may be available.

GlobeNewsWire7/29/2026Neutral
Should Value Investors Buy Phreesia (PHR) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Investment Research7/21/2026Positive
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Phreesia, Inc. of Class Action Lawsuit and Upcoming Deadlines – PHR

NEW YORK, July 14, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Phreesia, Inc. (“Phreesia” or the “Company”) (NYSE: PHR).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

GlobeNewsWire7/14/2026Neutral
PHR FINAL DEADLINE: ROSEN, A LEADING NATIONAL FIRM, Encourages Phreesia, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important July 13 Deadline in Securities Class Action - PHR

New York, New York--(Newsfile Corp. - July 13, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Phreesia, Inc. (NYSE: PHR) between May 8, 2025 and March 30, 2026, inclusive (the "Class Period"), of the important July 13, 2026 lead plaintiff deadline. SO WHAT: If you purchased Phreesia common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

Newsfile Corp7/13/2026Neutral
PHR DEADLINE TODAY: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Phreesia, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important July 13 Deadline in Securities Class Action - PHR

NEW YORK, July 13, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Phreesia, Inc. (NYSE: PHR) between May 8, 2025 and March 30, 2026, inclusive (the “Class Period”), of the important July 13, 2026 lead plaintiff deadline.

GlobeNewsWire7/13/2026Neutral
Bronstein, Gewirtz & Grossman LLC Urges Phreesia, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

New York, New York--(Newsfile Corp. - July 13, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Phreesia, Inc. (NYSE: PHR) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Phreesia securities between May 8, 2025 and March 30, 2026, both dates inclusive (the "Class Period").

Newsfile Corp7/13/2026Neutral

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on PHR and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More HEALTHCARE Stocks

Data last updated: 7/29/2026